High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer
暂无分享,去创建一个
M. Ychou | C. Borel | F. Caroli-Bosc | A. Kramar | J. Raoul | J. Seitz | Y. Merrouche | F. Desseigne | A. Hua | C. Couteau | J. Jacob | P. Lefebvre | F. Caroli‐Bosc | Ychou M. | Raoul J. | Desseigne F. | Borel C. | Caroli-Bosc F. | Jacob J. | Seitz J. | Kramar A. | Hua A. | Lefebvre P. | Couteau C. | Merrouche Y.